Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict.
Julia E C van SteenhovenBianca M den DekkerAnne KuijerPaul J van DiestPeter NieboerJohanna M ZuetenhorstAlex L Th ImholzSabine SieslingThijs van DalenPublished in: Breast cancer research and treatment (2020)
Deployment of the 70-GS changed patients' inclination to undergo adjuvant chemotherapy in one third of patients and decreased patients' decisional conflict.